Displaying 1 - 5 of 5 for Alzheimer's Disease
  • ADNI3 (H-39481)
    • This study tests whether serial magnetic resonance imaging, positron emission tomography, other biological markers, and clinical and neuropsychological assessment can be used together to measure mild cognitive impairment and Alzheimer’s progression.
  • Alzheimer's Study (H-41658)
    • The purpose of this study is to evaluate an investigational medication to see if it may reduce symptoms of agitation due to Alzheimer’s disease.
  • Healthy Aging Control Study (H-12081)
    • The purpose of this control study is to gain a better understanding of memory functioning in normal elderly control subjects.
  • Study on Gantenerumab for Alzheimer’s Disease: Graduate II (H-44419)
    • The purpose of the Graduate study is to evaluate the effects of an investigational drug called gantenerumab on people with early to mild Alzheimer’s Disease (AD).
  • TANGO Study (H-43013)
    • The purpose of this study is to find out whether an investigational medication can prevent or postpone the onset of symptoms of Alzheimer's disease.